Global Biobanking Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS10645 | Category: Agriculture | Pages: 112 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Biobanking, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking.

The Biobanking market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biobanking market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biobanking manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Biobanking market size in 2022 is 29300.0 million US dollars, and it is expected to be 51865.2 million US dollars by 2029, with a compound annual growth rate of 8.50% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Biobanking market include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), and Brooks Automation (U.S.). The share of the top 3 players in the Biobanking market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Biobanking market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Equipment accounted for XX% of Biobanking market in 2022. Consumables share of XX%.
Blood Products accounted for XX% of the Biobanking market in 2022. Human Tissues accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Biobanking market status and forecast by region.
Chapters 2-3: Segmented the global Biobanking market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Biobanking market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Biobanking market country segmentation data.
Chapter 10: Analyzes the main companies in the Biobanking industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
Thermo Fisher Scientific Inc. (U.S.)
Tecan Group Ltd. (Switzerland)
Qiagen N.V. (Germany)
Hamilton Company (U.S.)
Brooks Automation (U.S.)
TTP Labtech Ltd (U.K.)
VWR Corporation (U.S.)
Promega Corporation (U.S.)
Worthington Industries (Taylor Wharton - U.S.)
Chart Industries (U.S.)
Becton
Dickinson and Company (U.S.)
Merck KGaA (Germany)
Micronic (Netherlands)

Types list
Equipment
Consumables
Services
Software

Application list
Blood Products
Human Tissues
Nucleic Acids
Cell Lines

Table of Content

1 Biobanking Market Overview
1.1 Biobanking Product Overview
1.1.1 Biobanking Product Scope
1.1.2 Biobanking Market Status and Outlook
1.2 Global Biobanking Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Biobanking Market Size by Region (2018-2029)
1.4 Global Biobanking Historic Market Size by Region (2018-2023)
1.5 Global Biobanking Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Biobanking Market Size (2018-2029)
1.6.1 North America Biobanking Market Size (2018-2029)
1.6.2 Europe Biobanking Market Size (2018-2029)
1.6.3 Asia-Pacific Biobanking Market Size (2018-2029)
1.6.4 Latin America Biobanking Market Size (2018-2029)
1.6.5 Middle East & Africa Biobanking Market Size (2018-2029)
2 Biobanking Market Overview by Type
2.3 Global Biobanking Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Biobanking Historic Market Size by Type (2018-2023)
2.5 Global Biobanking Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Biobanking Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Biobanking Market Size Breakdown by Type
2.6.3 Asia-Pacific Biobanking Market Size Breakdown by Type
2.6.4 Latin America Biobanking Market Size Breakdown by Type
2.6.5 Middle East and Africa Biobanking Market Size Breakdown by Type
3 Biobanking Market Overview by Application
3.3 Global Biobanking Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Biobanking Historic Market Size by Application (2018-2023)
3.5 Global Biobanking Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Biobanking Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Biobanking Market Size Breakdown by Application
3.6.3 Asia-Pacific Biobanking Market Size Breakdown by Application
3.6.4 Latin America Biobanking Market Size Breakdown by Application
3.6.5 Middle East and Africa Biobanking Market Size Breakdown by Application
4 Biobanking Competition Analysis by Players
4.1 Global Biobanking Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biobanking as of 2022)
4.3 Date of Key Players Enter into Biobanking Market
4.4 Global Top Players Biobanking Headquarters and Area Served
4.5 Key Players Biobanking Product Solution and Service
4.6 Competitive Status
4.6.1 Biobanking Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Biobanking Market Segment by Country
5.1 North America Biobanking Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Biobanking Market Segment by Country
6.1 Europe Biobanking Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Biobanking Market Segment by Country
7.1 Asia-Pacific Biobanking Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Biobanking Market Segment by Country
8.1 Latin America Biobanking Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Biobanking Market Segment by Country
9.1 Middle East & Africa Biobanking Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  Thermo Fisher Scientific Inc. (U.S.)
10.1.1 Thermo Fisher Scientific Inc. (U.S.) Information
10.1.2 Business Overview
10.1.3 Thermo Fisher Scientific Inc. (U.S.) Biobanking Revenue, Gross Margin
10.1.4 Biobanking Products Offered
10.1.5 Thermo Fisher Scientific Inc. (U.S.) Recent Development
10.2  Tecan Group Ltd. (Switzerland)
10.2.1 Tecan Group Ltd. (Switzerland) Information
10.2.2 Business Overview
10.2.3 Tecan Group Ltd. (Switzerland) Biobanking Revenue, Gross Margin
10.2.4 Biobanking Products Offered
10.2.5 Tecan Group Ltd. (Switzerland) Recent Development
10.3  Qiagen N.V. (Germany)
10.3.1 Qiagen N.V. (Germany) Information
10.3.2 Business Overview
10.3.3 Qiagen N.V. (Germany) Biobanking Revenue, Gross Margin
10.3.4 Biobanking Products Offered
10.3.5 Qiagen N.V. (Germany) Recent Development
10.4  Hamilton Company (U.S.)
10.4.1 Hamilton Company (U.S.) Information
10.4.2 Business Overview
10.4.3 Hamilton Company (U.S.) Biobanking Revenue, Gross Margin
10.4.4 Biobanking Products Offered
10.4.5 Hamilton Company (U.S.) Recent Development
10.5  Brooks Automation (U.S.)
10.5.1 Brooks Automation (U.S.) Information
10.5.2 Business Overview
10.5.3 Brooks Automation (U.S.) Biobanking Revenue, Gross Margin
10.5.4 Biobanking Products Offered
10.5.5 Brooks Automation (U.S.) Recent Development
10.6  TTP Labtech Ltd (U.K.)
10.6.1 TTP Labtech Ltd (U.K.) Information
10.6.2 Business Overview
10.6.3 TTP Labtech Ltd (U.K.) Biobanking Revenue, Gross Margin
10.6.4 Biobanking Products Offered
10.6.5 TTP Labtech Ltd (U.K.) Recent Development
10.7  VWR Corporation (U.S.)
10.7.1 VWR Corporation (U.S.) Information
10.7.2 Business Overview
10.7.3 VWR Corporation (U.S.) Biobanking Revenue, Gross Margin
10.7.4 Biobanking Products Offered
10.7.5 VWR Corporation (U.S.) Recent Development
10.8  Promega Corporation (U.S.)
10.8.1 Promega Corporation (U.S.) Information
10.8.2 Business Overview
10.8.3 Promega Corporation (U.S.) Biobanking Revenue, Gross Margin
10.8.4 Biobanking Products Offered
10.8.5 Promega Corporation (U.S.) Recent Development
10.9  Worthington Industries (Taylor Wharton - U.S.)
10.9.1 Worthington Industries (Taylor Wharton - U.S.) Information
10.9.2 Business Overview
10.9.3 Worthington Industries (Taylor Wharton - U.S.) Biobanking Revenue, Gross Margin
10.9.4 Biobanking Products Offered
10.9.5 Worthington Industries (Taylor Wharton - U.S.) Recent Development
10.10  Chart Industries (U.S.)
10.10.1 Chart Industries (U.S.) Information
10.10.2 Business Overview
10.10.3 Chart Industries (U.S.) Biobanking Revenue, Gross Margin
10.10.4 Biobanking Products Offered
10.10.5 Chart Industries (U.S.) Recent Development
10.11  Becton
10.11.1 Becton Information
10.11.2 Business Overview
10.11.3 Becton Biobanking Revenue, Gross Margin
10.11.4 Biobanking Products Offered
10.11.5 Becton Recent Development
10.12  Dickinson and Company (U.S.)
10.12.1 Dickinson and Company (U.S.) Information
10.12.2 Business Overview
10.12.3 Dickinson and Company (U.S.) Biobanking Revenue, Gross Margin
10.12.4 Biobanking Products Offered
10.12.5 Dickinson and Company (U.S.) Recent Development
10.13  Merck KGaA (Germany)
10.13.1 Merck KGaA (Germany) Information
10.13.2 Business Overview
10.13.3 Merck KGaA (Germany) Biobanking Revenue, Gross Margin
10.13.4 Biobanking Products Offered
10.13.5 Merck KGaA (Germany) Recent Development
10.14  Micronic (Netherlands)
10.14.1 Micronic (Netherlands) Information
10.14.2 Business Overview
10.14.3 Micronic (Netherlands) Biobanking Revenue, Gross Margin
10.14.4 Biobanking Products Offered
10.14.5 Micronic (Netherlands) Recent Development
11 Biobanking Market Dynamics
11.1 Biobanking Industry Trends
11.2 Biobanking Growth Drivers
11.3 Biobanking Market Challenges
11.4 Biobanking Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Biobanking Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?